Evaluation of defibrillation efficacy at implantation is unnecessary

Cardiac Electrophysiology Clinics

Volumn 3, Issue 4, 2011, Pages 559-563

  Venkataraman, Ganesh ^a   Strickberger, S Adam ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

Defibrillation efficacy; Defibrillation threshold testing; Implantable defibrillator; Sudden cardiac death

Indexed keywords

DEFIBRILLATION; DEFIBRILLATOR; ELECTRODE; HEART DEATH; HEART MUSCLE CELL; HEART PACING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; PROBABILITY; RESUSCITATION; REVIEW; RISK ASSESSMENT; STROKE; SUDDEN DEATH; T WAVE;

EID: 82755189979     PISSN: 18779182     EISSN: 18779190     Source Type: Journal    
DOI: 10.1016/j.ccep.2011.08.013     Document Type: Review

References (26)

1. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 1997, 337:1576-1583.
2. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002, 346:877-883.
3. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005, 352:225-237.
4. Strickberger S.A., Hummel J.D., Daoud E., et al. Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation 1994, 90:868-872.
5. Strickberger S.A., Hummel J.D., Horwood L.E., et al. Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system. J Am Coll Cardiol 1994, 24:1069-1072.
6. Gold M.R., Foster A.H., Shorofsky S.R. Effects of an active pectoral-pulse generator shell on defibrillation efficacy with a transvenous lead system. Am J Cardiol 1996, 78:540-543.
7. Olsovsky M.R., Hodgson D.M., Shorofsky S.R., et al. Effect of biphasic waveforms on transvenous defibrillation thresholds in patients with coronary artery disease. Am J Cardiol 1997, 80:1098-1100.
8. Rattes M.F., Jones D.L., Sharma A.D., et al. Defibrillation threshold: a simple and quantitative estimate of the ability to defibrillate. Pacing Clin Electrophysiol 1987, 10:70-77.
9. Marchlinski F.E., Flores B., Miller J.M., et al. Relation of the intraoperative defibrillation threshold to successful postoperative defibrillation with an automatic implantable cardioverter defibrillator. Am J Cardiol 1988, 62:393-398.
10. Strickberger S.A., Daoud E.G., Davidson T., et al. Probability of successful defibrillation at multiples of the defibrillation energy requirement in patients with an implantable defibrillator. Circulation 1997, 96:1217-1223.
11. Higgins S., Mann D., Calkins H., et al. One conversion of ventricular fibrillation is adequate for implantable cardioverter-defibrillator implant: an analysis from the Low Energy Safety Study (LESS). Heart Rhythm 2005, 2:117-122.
12. Chen P.S., Feld G.K., Kriett J.M., et al. Relation between upper limit of vulnerability and defibrillation threshold in humans. Circulation 1993, 88:186-192.
13. Hwang C., Swerdlow C.D., Kass R.M., et al. Upper limit of vulnerability reliably predicts the defibrillation threshold in humans. Circulation 1994, 90:2308-2314.
14. Day J.D., Doshi R.N., Belott P., et al. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: risk reduction evaluation with implantable cardioverter-defibrillator implantations). Circulation 2007, 115:2382-2389.
15. Epstein A.E., Ellenbogen K.A., Kirk K.A., et al. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation 1992, 86:1206-1216.
16. Russo A.M., Sauer W., Gerstenfeld E.P., et al. Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2005, 2:456-461.
17. Healey J.S., Birnie D.H., Lee D.S., Ontario ICD Database Investigators, et al. Defibrillation testing at the time of ICD Insertion: an analysis from the Ontario ICD registry. J Cardiovasc Electrophysiol 2010, 21:1344-1348.
18. Pires L.A., Johnson K.M. Intraoperative testing of the implantable cardioverter-defibrillator: how much is enough?. J Cardiovasc Electrophysiol 2006, 17:140-145.
19. Michowitz Y., Lellouche N., Contractor T., et al. Defibrillation threshold testing fails to show clinical benefit during long-term follow-up of patients undergoing cardiac resynchronization therapy defibrillator implantation. Europace 2011, 13:683-688.
20. Calvi V., Dugo D., Capodanno D., et al. Intraoperative defibrillation threshold testing during implantable cardioverter-defibrillator insertion: do we really need it?. Am Heart J 2010, 159:98-102.
21. Bianchi S., Ricci R.P., Biscione F., et al. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Pacing Clin Electrophysiol 2009, 32:573-578.
22. Gula L.J., Massel D., Krahn A.D., et al. Is defibrillation testing still necessary? a decision analysis and Markov model. J Cardiovasc Electrophysiol 2008, 19:400-405.
23. Blatt J.A., Poole J.E., Johnson G.W., et al. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008, 52:551-556.
24. Tokano T., Bach D., Chang J., et al. Effect of ventricular shock strength on cardiac hemodynamics. J Cardiovasc Electrophysiol 1998, 9:791-797.
25. Birnie D., Tung S., Simpson C., et al. Complications associated with defibrillation threshold testing: the Canadian experience. Heart Rhythm 2008, 5:387-390.
26. Healey J.S., Hohnloser S.H., Glikson M., et al. A novel design for a randomized trial to test if ICD implantation without any defibrillation testing is as effective as standard treatment. Heart Rhythm 2009, 6:S374.